Registry-listed formulations

succinylated gelatin · mesh:C060085

Each study is counted once in the molecule profile. Registry products remain separate. Naming an ingredient does not establish that products are interchangeable or what participants received.

1 source entries across 1 studies. This list may not include all unresolved or historical entries.

  • succinylated gelatin injectionRegistry intervention

    Linked study entry; product equivalence not established

    View study and source

Success Metrics

Clinical Success Rate
100.0%

Based on 1 completed trials

Completion Rate
100%(1/1)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

Phase 2
1
33%
Phase 4
1
33%
Not Applicable
1
33%

Phase Distribution

0

Early Stage

1

Mid Stage

1

Late Stage

Phase Distribution3 total trials
Phase 2Efficacy & side effects
1(33.3%)
Phase 4Post-market surveillance
1(33.3%)
N/ANon-phased studies
1(33.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

1 of 1 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

3

all time

Status Distribution
Active(1)
Completed(1)
Other(1)

Detailed Status

Not yet recruiting1
unknown1
Completed1

Development Timeline

Analytics

Development Status

Total Trials
3
Active
0
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 21 (33.3%)
Phase 41 (33.3%)
N/A1 (33.3%)

Trials by Status

not_yet_recruiting133%
unknown133%
completed133%

Recent Activity

0 active trials
Showing 3 of 3
not_yet_recruitingnot_applicable

Clinical Study on the Effectiveness and Safety of Succinylated Gelatin Injection

NCT06977763
completedphase_2

Succinylated Gelatin for Prevention of Fluid Retention in Patients With Breast Cancer Receiving Docetaxel Chemotherapy

NCT04637308
unknownphase_4

The Effect of Succinylated Gelatin on the Blood Viscosity and Oxygen Delivery

NCT02631356

Clinical Trials (3)

Showing 3 of 3 trials
NCT06977763Not Applicable

Clinical Study on the Effectiveness and Safety of Succinylated Gelatin Injection

Not Yet Recruiting
NCT04637308Phase 2

Succinylated Gelatin for Prevention of Fluid Retention in Patients With Breast Cancer Receiving Docetaxel Chemotherapy

Completed
NCT02631356Phase 4

The Effect of Succinylated Gelatin on the Blood Viscosity and Oxygen Delivery

Unknown

All 3 trials loaded

Drug Details

Intervention Type
Drug
Total Trials
3

Names & Codes

Trade Names

Gelofusin